. . . . . . . "[A genomic signature designed to assess the activity of the estrogen-related receptor alpha (ERR?) was used to�profile more than 800 breast tumors, revealing a shorter disease-free survival in patients with tumors exhibiting elevated receptor activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:31+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .